On November 15, 2019 Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on developing curative cell therapies for cancer, reported its participation in the following upcoming investor conference (Press release, Unum Therapeutics, NOV 15, 2019, View Source [SID1234551380]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray 31st Annual Healthcare Conference, New York
Date: December 5, 2019, New York, NY
Presentation time: 12:10 p.m. ET
Presenter: Chuck Wilson, Ph.D., President and Chief Executive Officer
The presentation will be webcast live here and archived for approximately 90 days.